117174-53-5 Usage
Uses
Used in Pharmaceutical Applications:
(2S,3R)-1-(6-Amino-purin-9-yl)-5-benzyloxy-pentane-2,3-diol is utilized as a pharmaceutical intermediate for the development of novel therapeutic agents. Its unique structure and functional groups contribute to its potential as a precursor in the synthesis of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Organic Synthesis:
In the field of organic synthesis, (2S,3R)-1-(6-Amino-purin-9-yl)-5-benzyloxy-pentane-2,3-diol serves as a key building block for the creation of more complex organic compounds. Its versatile structure allows for further functionalization and modification, enabling the synthesis of a wide range of molecules with diverse applications.
Used in Chemical Biology:
(2S,3R)-1-(6-Amino-purin-9-yl)-5-benzyloxy-pentane-2,3-diol is employed as a molecular probe in chemical biology to study the interactions between small molecules and biological targets. Its specific structure and functional groups facilitate the investigation of molecular recognition and binding events, providing insights into biological processes and potential therapeutic interventions.
Used in Drug Delivery Systems:
(2S,3R)-1-(6-Amino-purin-9-yl)-5-benzyloxy-pentane-2,3-diol can be incorporated into drug delivery systems to improve the efficacy and targeting of therapeutic agents. Its unique structure may allow for the development of novel carriers or conjugates that enhance the delivery of drugs to specific cells or tissues, thereby increasing the therapeutic potential and reducing side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 117174-53-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,1,7 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 117174-53:
(8*1)+(7*1)+(6*7)+(5*1)+(4*7)+(3*4)+(2*5)+(1*3)=115
115 % 10 = 5
So 117174-53-5 is a valid CAS Registry Number.